Dimensional Fund Advisors LP Syndax Pharmaceuticals Inc Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 487,647 shares of SNDX stock, worth $7.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

487,647

Previous 465,882 4.67%

Holding current value

$7.83 Million

Previous $5.73 Million 20.19%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$8.9 - $14.15 $193,708 - $307,974	21,765 Added 4.67%	487,647 $4.57 Million
Q1 2025 May 13, 2025	BUY	$12.29 - $16.38 $1.65 Million - $2.2 Million	134,582 Added 40.62%	465,882 $5.73 Million
Q4 2024 Feb 13, 2025	BUY	$12.52 - $21.81 $3.55 Million - $6.18 Million	283,577 Added 594.21%	331,300 $4.38 Million
Q3 2024 Nov 07, 2024	SELL	$17.93 - $24.81 $402,671 - $557,182	-22,458 Reduced 32.0%	47,723 $918,000
Q2 2024 Aug 09, 2024	SELL	$18.82 - $23.79 $723,892 - $915,058	-38,464 Reduced 35.4%	70,181 $1.44 Million
Q1 2024 May 10, 2024	SELL	$19.71 - $24.57 $12,969 - $16,167	-658 Reduced 0.6%	108,645 $2.59 Million
Q4 2023 Feb 07, 2024	BUY	$11.39 - $21.67 $36,026 - $68,542	3,163 Added 2.98%	109,303 $2.36 Million
Q3 2023 Nov 09, 2023	SELL	$14.52 - $21.77 $7.09 Million - $10.6 Million	-488,322 Reduced 82.15%	106,140 $1.54 Million
Q2 2023 Aug 09, 2023	SELL	$19.35 - $22.31 $14 Million - $16.2 Million	-725,763 Reduced 54.97%	594,462 $12.4 Million
Q1 2023 May 12, 2023	BUY	$20.66 - $28.98 $1.12 Million - $1.57 Million	54,096 Added 4.27%	1,320,225 $27.9 Million
Q4 2022 Feb 09, 2023	BUY	$20.64 - $26.24 $2.97 Million - $3.77 Million	143,677 Added 12.8%	1,266,129 $32.2 Million
Q3 2022 Nov 10, 2022	BUY	$18.51 - $24.79 $2.99 Million - $4 Million	161,346 Added 16.79%	1,122,452 $27 Million
Q2 2022 Aug 12, 2022	BUY	$13.64 - $19.48 $1.05 Million - $1.5 Million	76,772 Added 8.68%	961,106 $18.5 Million
Q1 2022 May 13, 2022	BUY	$14.84 - $22.15 $1.35 Million - $2.01 Million	90,634 Added 11.42%	884,334 $15.4 Million
Q4 2021 Feb 09, 2022	BUY	$15.23 - $22.47 $2.22 Million - $3.27 Million	145,674 Added 22.48%	793,700 $17.4 Million
Q3 2021 Nov 12, 2021	BUY	$13.87 - $19.8 $2.03 Million - $2.9 Million	146,228 Added 29.14%	648,026 $12.4 Million
Q2 2021 Aug 12, 2021	SELL	$13.42 - $25.18 $2.79 Million - $5.23 Million	-207,841 Reduced 29.29%	501,798 $8.62 Million
Q1 2021 May 14, 2021	SELL	$19.28 - $24.59 $1.27 Million - $1.62 Million	-66,069 Reduced 8.52%	709,639 $15.8 Million
Q4 2020 Feb 25, 2021	BUY	$15.1 - $26.44 $11.7 Million - $20.5 Million	775,708 New	775,708 $17.3 Million

Others Institutions Holding SNDX

# of Institutions

247

Shares Held

100M

Call Options Held

1.28M

Put Options Held

1.29M

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $908M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Syndax Pharmaceuticals Inc Transaction History